Back to GetFilings.com

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

For the quarterly period ended March 31, 2005

OR

For the transition period from              to             

Commission file number 000-27548

LIGHTPATH TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

http://www.lightpath.com

2603 Challenger Tech Ct. Suite 100

Orlando, Florida 32826

(Address of principal executive offices)

(ZIP Code)

(407) 382-4003

(Registrant’s telephone number, including area code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    YES  ¨    NO  x

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date:

3,342,900 shares of common stock, Class A, $.01 par value, outstanding as of April 29, 2005

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Form 10-Q

Index

2

Table of Contents

Item 1. Financial Statements

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Balance Sheets

(unaudited)

The accompanying notes are an integral part of these unaudited consolidated statements.

3

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statement of Operations

(unaudited)

The accompanying notes are an integral part of these unaudited consolidated statements.

4

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Condensed Consolidated Statements of Cash Flows

(unaudited)

The accompanying notes are an integral part of these unaudited consolidated statements.

5

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with the requirements of Article 10 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. These consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and related notes, included in its Form 10-K for the fiscal year ended June 30, 2004, filed with the Securities and Exchange Commission.

These consolidated financial statements are unaudited but include all adjustments, which include normal recurring adjustments, which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company for the interim periods presented. Results of operations for interim periods are not necessarily indicative of the results that may be expected for the year as a whole.

History and Liquidity

History: LightPath Technologies, Inc. (“LightPath” or the “Company”) was incorporated in Delaware in 1992. In order to pursue a strategy of supplying hardware to the telecommunications industry, in April 2000, the Company acquired Horizon Photonics, Inc. (Horizon), and in September 2000 the Company acquired Geltech, Inc (Geltech). During fiscal 2003, in response to sales declines in the telecommunications industry, the operations of Horizon in California and LightPath in New Mexico were consolidated into the former Geltech facility in Orlando, Florida.

The Company is engaged in the production of precision molded aspherical lenses, GRADIUM^® glass lenses, collimators and isolator optics used in various markets, including industrial, medical, defense, test and measurement and telecommunications. As used herein, the terms “LightPath,” “Company,” “we,” “us,” or “our,” refer to LightPath individually or, as the context requires, collectively with its subsidiaries on a consolidated basis.

Liquidity: During fiscal years 2003 and 2004, progress was made to reduce cash outflow. In fiscal 2003, cash used in operations was approximately $9.7 million. In fiscal 2004, cash used in operations was $2.5 million. The Company’s operating plan in fiscal 2005 includes reaching positive cash flow from operations during the year. However, through March 31, 2005 that has not yet occurred and there can be no assurance that the plan can be fully achieved and the Company has no firm commitments for any material future financing, if needed, at this time. At March 31, 2005, the Company has a cash and cash equivalent balance of approximately $1.5 million. The Company may seek external debt or equity financing in 2005 or thereafter, if it can be obtained in an amount and on terms that are acceptable to us, though no assurance can be made that financing will be available. With regard to prospective equity financing, the Company’s stockholders approved a proposal at the annual meeting of stockholders on October 20, 2004 to permit the Board to enter into one or more transactions to issue up to 1.2 million additional common shares or equivalents, for such purposes as determined by the Board of Directors. The Company does not currently anticipate relying on such approval for any equity issuances.

As heretofore stated, significant risk and uncertainty remains in achieving the goal of generating cash flow from operations. The Company did not generate positive cash flow from operations in the quarter or the nine months ended March 31, 2005. The aforementioned 2005 operating plan and related financial projections the Company has developed anticipate further sales growth, continuing improvement in margins based on production efficiencies and reductions in product costs, offset by higher selling, administrative and new product development costs. Factors which could adversely affect cash balances in future quarters include, but are not limited to, a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency (yield) improvements not being realized, and increases in other discretionary spending required to effectively compete in our markets.

As a result of the Company’s cash flow position, should the Company find it desirable or necessary to issue additional equity securities or debt that may be convertible into or exercisable for equity securities, the action would have the effect of increasing our fully diluted shares outstanding and ultimately diluting our operating results (net earnings or net loss) per share and would dilute the voting power of current stockholders who do not acquire sufficient additional shares to maintain their percentage of share ownership.

6

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

1. Significant Accounting Policies

Consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Cash and cash equivalents consist of cash in the bank and temporary investments with maturities of 90 days or less when purchased.

Inventories, which consist principally of raw materials, lenses, isolators, collimators and components are stated at the lower of cost or market, on a first-in, first-out basis. Inventory costs include materials, labor and manufacturing overhead.

Property and equipment are stated at cost less accumulated depreciation, which is calculated using the straight-line method over the estimated useful lives of the related assets ranging from three to seven years. Platinum molds, less estimated salvage value which is most of the acquisition cost, are depreciated on a straight-line basis over the estimated useful lives ranging from one to two years.

Long-lived assets are recorded in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144, Accounting for Impairment or Disposal of Long-Lived Assets. SFAS No. 144 provides a single accounting model for long-lived assets to be disposed of. SFAS No. 144 also changes the criteria for classifying an asset as held for sale; and broadens the scope of businesses to be disposed of that qualify for reporting as discontinued operations and changes the timing of recognizing losses on such operations.

In accordance with SFAS No. 144, long-lived assets, such as property, plant, and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimates of undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposed group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheet.

Intangible assets, consisting of customer list and supply contracts, licenses, patents, trademarks, and others, are recorded at cost. Upon issuance of the license, patent or trademark, these assets are being amortized on the straight-line basis over the estimated useful life of the related assets ranging from ten to seventeen years. Customer list and supply contracts and other intangibles are being amortized on a straight-line basis over the estimated period of benefit ranging from two to five years.

The Company accounts for goodwill and intangible assets in accordance with SFAS No. 142, Goodwill and Other Intangible Assets. SFAS 142 eliminates the amortization of goodwill and other intangible assets that have indefinite useful lives. Amortization will continue to be recorded for intangible assets with definite useful lives. SFAS 142 also requires at least an annual impairment review of goodwill and other intangible assets. The Company evaluates its intangible assets for impairment in accordance with SFAS 144.

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are computed on the basis of differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based upon enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances have been established to reduce deferred tax assets to the amount expected to be realized.

7

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

Revenue is generally recognized from product sales when products are shipped to the customer, provided that LightPath has received a valid purchase order, the price is fixed, title has transferred, collection of the associated receivable is reasonably assured, and there are no remaining significant obligations.

New product development costs are expensed as incurred.

Stock-based compensation is accounted for using the intrinsic value method as prescribed by APB Opinion No. 25, Accounting for Stock Issued to Employees, under which no compensation expense is recognized when the exercise price of the employee’s stock option equals or exceeds the market price of the underlying stock on the date of grant and other requirements are met. For stock options granted to non-employees, stock-based compensation is determined using the fair value method as prescribed by SFAS 123, Accounting for Stock-Based Compensation. Under the intrinsic value method, compensation expense for a restricted stock award is recognized when a portion of the award “vests,” that is, the restrictions fully lapse. The Company has adopted the disclosure provisions of SFAS No. 148, Accounting for Stock-Based Compensation – Transition and Disclosure.

The following table illustrates the effect on net loss and loss per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.

In December 2004, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards (SFAS) No. 123R, “Share-Based Payments.” SFAS No. 123R revises SFAS No. 123, “Accounting for Stock-Based Compensation” and generally requires the cost associated with employee services received in exchange for an award of equity instruments be measured based on the grant-date fair value of the award and recognized in the financial statements over the period during which employees are required to provide service in exchange for the award. SFAS No. 123R also provides guidance on how to determine the grant-date fair value for awards of equity instruments as well as alternative methods of adopting its requirements. SFAS No. 123R was originally to have been effective for the beginning of the first annual reporting period after June 15, 2005, which would have been the Company’s fiscal year 2006. On April 14, 2005, the Securities and Exchange Commssion adopted a new rule extending the date for compliance with SFAS No. 123R to the beginning of the next fiscal year, instead of the next reporting period, that begins after June 15, 2005. The financial statements for the Company, which has a June 30 year-end, must comply with SFAS No. 123R when the interim financial statements for the quarter beginning July 1, 2005 are filed with the Commission.

8

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

During the second quarter of fiscal 2005 (three months ended December 31, 2004), the Company’s Compensation Committee considered the matter of the effect of prospective future recognition of compensation expense under SFAS 123R from still outstanding stock options that are significantly “out-of-the money.” The Compensation Committee passed a resolution to accelerate the remaining vesting of such options. These options, totalling 9,900 original shares, held by 18 employees, of which 4,378 shares were accelerated by this resolution, were granted from January 2001 to January 2002 when the Company’s stock price ranged from approximately $93 per share to approximately $27 per share (compared to a trailing 12 month range of $3.25 to $7.52 per share as of January 31, 2005). These options had an original fair value measurement ranging from approximately $67 to $23 per share at the time of the grant and a total remaining prospective recognition of fair value compensation expense of approximately $149,000 at the time of the action by the Compensation Committee. While the Compensation Committee believes that SFAS 123R is a fair resolution to the longstanding issue of equity-based incentive compensation, it does not believe there is true value to the Company by the future recognition of the remaining original fair value expense of options that no longer have any material calculable fair value. Such instruments no longer have any economic value to the employees holding them and no retentive value to the Company with regard to those employees. Once the Company becomes subject to the provisions of SFAS 123R, the Company will recognize expense in accordance with its provisions.

Management makes estimates and assumptions during the preparation of the Company’s consolidated financial statements that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes available, which in turn could impact the amounts reported and disclosed herein.

Fair values of financial instruments of the Company are disclosed as required by Statement of Financial Accounting Standards No. 107, Disclosures about Fair Values of Financial Instruments. The carrying amounts of cash and cash equivalents, trade accounts receivable, accounts payable and accrued liabilities approximate fair value.

Reclassification of certain items in the prior year’s consolidated financial statements and notes to consolidated financial statements have been reclassified to conform with the 2005 presentation. These reclassifications had no effect on stockholders’ equity or net earnings.

2. Inventories

The components of inventories include the following at:

9

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

3. Property and Equipment

During the first nine months of fiscal 2005 the Company disposed of equipment with a book value of $89,086, resulting in a gain of $23,541. There were no disposals during the third quarter of fiscal 2005.

4. Intangible Assets

The following table discloses information regarding the carrying amounts and associated accumulated amortization for intangible assets subject to amortization after the adoption of SFAS 142:

5. Stockholders’ Equity

The Company does not have any preferred stock outstanding.

6. Net Loss Per Share

Basic net loss per share is computed based upon the weighted average number of shares of Class A common stock outstanding, not including unvested restricted stock, during each period presented. The computation of diluted net loss per share does not differ from the basic computation because potentially issuable securities would be anti-dilutive. As such, the numerator and the denominator used in computing both basic and diluted net loss per share are equal.

7. Stock-Based Compensation

The following is a summary of stock-based compensation amounts included in each of the cost and expense categories:

10

Table of Contents

LIGHTPATH TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements – (Unaudited)

March 31, 2005 and 2004

8. Segment Data

The Company produces passive optical equipment. This one line of business represents 100% of consolidated revenue from production.

9. Contingencies

In 2000, a group of holders of Class E Common Stock commenced an action in a state court in Texas (the “Texas Action”). Plaintiffs in the Texas Action made various allegations regarding the circumstances surrounding the issuance of the Class E Common Stock and sought damages based upon those allegations. Management believes the allegations underlying the Texas Action are without merit. Since being filed, a Texas court has granted the Company’s motion for Summary Judgment. An appellate court subsequently denied the plaintiff’s motion for reconsideration and the Texas Supreme Court has dismissed a plaintiff’s petition for a review for want of jurisdiction. The plaintiffs subsequently filed another appeal with the 14^th District Court of Appeals in Texas. On November 3, 2004, arguments were heard in that court by a panel of judges. A ruling by the 14^th District Court of Appeals, as to whether to overturn the Summary Judgment and allow a new trial or to affirm that decision, is not expected until the middle of calendar 2005.

The Company licenses certain patents from the University of Florida Research Foundation, Inc. (“UF’). UF notified us that we were in default under the terms of the Amended and Restated License Agreement (“License”) for failure to pay certain royalties. UF claims that we owe $83,000 in unpaid royalties. In April, UF sent its letter of termination of the license. While we dispute the amount owed and we believe that an amicable result can be reached with UF, the termination of the license agreement does not materially adversely affect our business.

During the quarter ended September 30, 2004, the Company settled an employee harassment suit relating to an action filed against the Company’s Geltech subsidiary concerning a pre-acquisition, 1998 incident. The Company has made payments to both the plaintiff and plaintiff’s attorneys totaling $70,000. The action was dismissed upon reaching the settlement.

The Company may also be involved, from time to time, in various claims or actions arising in the normal course of business. After taking into consideration legal counsel’s evaluation of such matters, management is of the opinion that any outcomes will not have a significant effect on the Company’s financial position or results of operations.

11

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward looking statements made by or on behalf of the Company. All statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Report, other than statements of historical facts, which address activities, events or developments that the Company expects or anticipates will or may occur in the future, including such things as future capital expenditures, growth, product development, sales, business strategy and other similar matters are forward-looking statements. These forward-looking statements are based largely on the Company’s current expectations and assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Actual results could differ materially from the forward-looking statements set forth herein as a result of a number of factors, including, but not limited to, the need for additional financing, intense competition in various aspects of its business and other risks described in the Company’s reports on file with the Securities and Exchange Commission. In light of these risks and uncertainties, all of the forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The comments herein are as of the date of this filing and the Company undertakes no obligation to update or revise any of the forward-looking statements contained herein.

Overview

Historical: We are in the business of supplying users with glass lenses and other specialty optical products, which have applications in a number of different industries. Due to the emergence of optical technologies in communications, networking and data storage products in the late 1990’s, there was a significant surge in demand for our products, particularly in the period represented by our fiscal 1999-2001 years. During this period, our revenues increased from less than $2 million in sales to approximately $25 million due to both acquisitions (to add glass lens production capacity and market presence, and isolators to our existing line of collimators and proprietary glass lenses) and organic product line growth.

During fiscal 2002, optical component markets experienced a severe downturn that resulted in a significant decline in the demand for our products. By fiscal 2003, our sales had contracted to just under $7 million. The business infrastructure was too large and diverse to support a business of this reduced size and a decision was made in late fiscal 2002 and implemented during fiscal 2003 to close our isolator production facility in California and our headquarters and collimator and lens production facility in New Mexico. The productive capacity in these locations was moved to excess space in the acquired lens business facility in Florida and production of all of the aforementioned products continues there. These moves were completed by June 30, 2003, resulting in a significant reduction in the net cash used by the business.

Nevertheless, the ongoing cash used by the business remains negative each quarter and management, while continuing to work toward reducing costs and producing product at lower per-unit costs, believes that increased sales volumes going forward will be required to permit the Company to be self-sustaining in terms of a regular and positive cash flow from operations. In order to increase sales volumes, during fiscal 2004 and 2005 to-date, the sales force was strengthened through changes and additions of personnel. In early fiscal 2004 a Senior Vice President of Sales and Marketing was added to lead the effort to bring LightPath’s capabilities to the marketplaces of specialty and high-performance optics users.

How we operate: The Company has continuing sales of two basic types: occasional sales via ad-hoc purchase orders of mostly standard product configurations (our “turns” business) and the more challenging and potentially more rewarding business with characteristics of the semi-conductor industry. In this latter type of business we work with a customer to help them determine optical specifications and even create certain optical designs for them, including complex multi-component designs that we call “engineered assemblies.” That is followed by “sampling” them small numbers of the product for their test and evaluation. Thereafter, should the customer conclude that our specification or design is the best solution to their product need, we negotiate and “win” a contract (sometimes called a “design win”) – whether of a “blanket purchase order” type or a supply agreement. The strategy is to create an annuity revenue stream that makes the best use of our production capacity as compared to the turns business, which is unpredictable and uneven. A key business objective is to convert as much of our business to the design win and annuity model as is possible. We have several challenges in doing so:

12

Table of Contents

Despite these challenges to winning more “annuity” business, we nevertheless believe we can be successful in procuring this business because of our unique capabilities in optical design engineering that we make available on the merchant market, a market that we believe is underserved in this area of service offering. Additionally, we believe that we offer value to some customers as a second or backup source of supply in the United States should they be unwilling to commit all of their source of supply of a critical component to a foreign merchant production source. We also continue to have the proprietary GRADIUM lens glass technology and the ability to make unique, elemental-impregnated porous-silica optical media that can be used in various test and measurement and sensing applications.

Our key indicators:

Sales Backlog – We believe that sales growth will be our best indicator of success. Our best view into the efficacy of our sales efforts is in our “order book.” Our order book equates to sales “backlog.” It has a quantitative and a qualitative aspect: quantitatively, our backlog’s prospective dollar value and qualitatively, what percent of the backlog is scheduled by the customer for date-certain delivery. We define our “disclosure backlog” as that which is requested by the customer for delivery within one year and which is reasonably likely to remain in the backlog and be converted into revenues. This includes customer purchase orders and may include amounts under supply contracts if they meet the aforementioned criteria. At March 31, 2005, our disclosure backlog was approximately $2,488,000; at March 31, 2004, it was approximately $2,810,000. We believe this decrease in the disclosure backlog is attributable to weakness in our remaining communication market customers, which more than offset the growth in our sales to customers in the industrial, medical, and defense markets.

At December 31, 2004, our disclosure backlog was $2,980,000, indicating that our recent sales growth rate may slow in the quarter ending June 30, 2005.

Inventory Levels - Inventory levels are managed by the Company to minimize investment in working capital but still have the flexibility to meet customer demand to a reasonable degree. While the mix of inventory is an important factor, including adequate safety stocks of long lead-time materials, an important aggregate measure of inventory in all phases of production is the quarter’s ending inventory expressed as a number of days worth of the quarter’s cost of sales, also known as “days cost of sales in inventory,” or “DCSI.” It is calculated by dividing the quarter’s ending inventory by the quarter’s cost of goods sold, multiplied by 365 and divided by 4. Generally, a lower DCSI measure equates to a lesser investment in inventory and therefore more efficient use of capital. At March 31, 2005, our DCSI was 69 compared to 63 at March 31, 2004.

Accounts Receivable Levels and Quality - Accounts receivable levels are similarly managed by the Company to minimize investment in working capital. We measure the quality of receivables by the proportions of the total that are at various increments past due from our normally extended terms, which are generally 30 days. The most important aggregate measure of accounts receivable is the quarter’s ending balance of net accounts receivable expressed as a number of days worth of the quarter’s net revenues, also known as “days sales outstanding,” or “DSO.” It is calculated by dividing the quarters ending net accounts receivable by the quarter’s net revenues, multiplied by 365 and divided by 4. Generally, a lower DSO measure equates to a lesser investment in accounts receivable and therefore more efficient use of capital. At March 31, 2005, our DSO was 53 compared to 59 at March 31, 2004.

Other Key Indicators – Other key indicators include various operating metrics, some of which are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as units of shippable output by major product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes. The Company believes that its non-financial production indicators, such as those noted in this paragraph, are proprietary information.

13

Table of Contents

Liquidity and Capital Resources

We engage in continuing efforts to keep costs under control as we seek necessary sales growth, however we may not succeed and we may find it necessary to raise additional capital. Should capital not be available to the Company at reasonable terms, other actions may become necessary in addition to cost controls and vigorous sales activities. These actions may include exploring strategic options for the sale of the Company or of some of the Company’s product and production capabilities. The Company has no firm commitments for any future financing at this time and we have a book cash balance of approximately $1.4 million at April 30, 2005.

In the quarter ended December 31, 2004, the Company entered into a $75,000 capital equipment lease for equipment to support our molded optics production. If additional capital expenditures are warranted, the Company will seek similar capital equipment lease financing. It is uncertain whether the Company will be able to consistently have access to this source of capital.

Further improvement in cash flow, which will initially mean a reduction in cash used, is expected to be primarily a function of sales increases and, to a lesser extent, margin improvements. Sales increases are expected to be the most important source of future reduction in operating cash outflow. Sales management has been strengthened and focused efforts are underway in order to try to penetrate new industrial optics customers.

Our fiscal 2005 operating plan and related financial projections anticipate sales growth, improving margins based on production efficiencies and reductions in both product costs and expected selling and administrative expenditures. Not all of these factors have fully materialized at the end of the first nine months of the fiscal 2005 year.

Factors which could adversely affect cash balances in future quarters include, but are not limited to, a decline in revenue or a lack of anticipated sales growth, poor cash collections from our accounts receivables, increased material costs, increased labor costs, planned production efficiency improvements not being realized and increases in other discretionary spending, particularly sales and marketing related.

Sources and Uses of Cash

The Company’s recurring sources and uses of cash are quite straightforward: we collect receivables after invoicing customers for product shipments and we pay vendors for materials and services purchased. Other significant uses of cash are payments to employees for wages and compensation and payments to providers of employee benefits. All other sources and uses of cash are typically immaterial. However we do make expenditures for capital goods, and have received small amounts of cash in the last several quarters for the sale of surplus equipment that we moved from New Mexico or California attendant to the closure and consolidation of those facilities. For some time the net balance of these cash flows have been negative, meaning a net use of cash. This net use of cash has been met by drawing down on the Company’s cash and cash equivalent balances.

In the future, the Company may be required to replenish its cash and cash equivalent balances through the sale of equity securities or by obtaining debt. With regard to prospective equity financing, the Company’s stockholders approved a proposal at the annual meeting of stockholders on October 20, 2004 to permit the Board to enter into one or more transactions to issue up to 1.2 million additional common shares or equivalents, for such purposes as determined by the Board of Directors. There can be no assurances that such financing will be available to the Company and as a result there is significant risk to the Company in terms of having limited cash resources with which to pursue business opportunities. As a result of this risk, should it materialize, the Company may be generally unable to sustain its growth plan or even to maintain its current levels of business. Either of these outcomes would materially adversely affect the Company’s results of operations and its stock price.

14

Table of Contents

There are certain uses of the Company’s cash that are contractually or commercially committed. Those are presented below as of March 31, 2005:

Contractual Obligations – Payments Due By Period (dollars in 000’s)

The Company does not engage in any activities involving variable interest entities or off-balance sheet financing.

Results of Operations

Fiscal Third Quarter: Three months ended March 31, 2005 compared to the three months ended March 31, 2004

Revenues:

Our revenues totaled approximately $3,065,000 for the third quarter of fiscal 2005, an increase of approximately $1,114,000, or 57% compared to revenues for the third quarter of fiscal 2004. The increase was primarily attributed to higher volumes and higher average selling prices caused by a mix shift to higher value-added products. Specifically, average selling prices across all of our product lines accounted for $151,000, or 12% of the sales increase, while volume increases across all of our product lines accounted for $1,071,000, or 82% of the sales increase. The remaining $87,000 of sales increase is the net effect of other revenues and the arithmetical intersection of the changes in price and volume change in the quarter. New products (defined as those introduced in the last twelve months) accounted for sales of $248,000, or 8% of sales in the quarter. New products are defined as unit volume increases in the price and volume disclosures offered herein.

Cost of Sales:

In the third quarter of fiscal 2005, consolidated cost of sales of approximately $2,269,000 was approximately 74% of product sales, versus the comparable period of fiscal 2004 in which we reported cost of sales of approximately $1,625,000, or 83% of product sales. This improvement in gross margin (from 17% to 26% of sales) is primarily due to efficiencies that we are gaining as we reach a higher level of capacity utilization in our Orlando facility. Secondarily, it is also attributed to materials cost reductions that we have been able to negotiate on a number of our raw materials and components. We continue to make efforts to reduce manufacturing costs as a percent of sales through cost reductions and both process and yield improvements.

Selling, General and Administrative:

During the third quarter of fiscal 2005, selling, general and administrative costs (SG&A) was approximately $830,000 or 27% of product sales, which was a decrease of approximately $556,000 or 40% compared to the third quarter of fiscal 2004. The decrease was due to a reduction in compensation-related expenses, investor relations, outside services and general administrative expenses. While in the future we intend to manage SG&A costs to be generally in proportion to our business levels, we are considering adding to our sales force while seeking other cost reductions such as sub-leasing a portion of or restructuring the lease related to the Orlando facility to reduce rent cost.

15

Table of Contents

New Product Development:

New product development costs (NPD) decreased by approximately $15,000 or 6% to approximately $225,000 or 7% of product sales in the third quarter of fiscal 2005 versus the third quarter of fiscal 2004, due primarily to lower spending for materials for product development work, which are expensed in the period they are acquired. As we work to achieve profitability at our current level of business, NPD spending will consist of product development work to meet specific customer design requests that can lead to new and continued sales.

Amortization of Intangibles:

At the end of the first quarter of fiscal 2005, a major component of our identifiable, amortizing intangible assets became fully amortized and, therefore, for the third quarter of fiscal 2005 amortization expense from intangibles was reduced by approximately $427,000 in the quarter. Other identifiable intangibles resulting from the Company’s two acquisitions in fiscal 2000 and 2001 have also concluded their amortization or are nearing the end of their amortizable lives, further reducing amortization expenses. The remaining amortization from the acquisitions will be concluded in early fiscal 2006 after which we anticipate amortization expense will be immaterial.

Loss/(Gain) on Sales of Assets:

Loss on sale of assets was approximately $13,000 in the third quarter of fiscal 2005 compared with a gain of $6,000 in the third quarter of fiscal 2004. The loss in fiscal 2005 relates to the accelerated settlement of a note receivable related to the financing of the disposition of a former subsidiary; the assets sold in 2004 were a part of our program to dispose of excess equipment from our consolidation of facilities that occurred between December 2002 and June 2003. No significant additional sales or cash proceeds from this excess equipment are expected.

Other Income (Expense):

Due to low balances in our cash equivalents and generally low interest rates available on those balances, our investment income is immaterial in each of the two quarters. During the third quarter of fiscal 2005 we did not incur amortization expense related to warrant issuance costs; in the same quarter in fiscal 2004, we recorded amortization of warrant issuance cost of approximately $79,000 for a warrant that was issued in the first quarter of fiscal 2004.

Net Loss:

Net loss was approximately $306,000 during the third quarter of fiscal 2005. Included in the net loss were non-cash items of approximately $0.3 million (primarily intangibles amortization and stock based compensation). This compares with the third quarter of fiscal 2004, in which we reported a net loss of $1,070,000 including $0.6 million in non-cash charges. The $764,000 decrease in net loss was due primarily to the higher gross margin ($0.5 million), reduced SG&A costs ($0.6 million) and reduced amortization expenses ($0.4 million) partially offset by reduced other income ($0.7 million). The net loss of $306,000 for the third quarter of fiscal 2005 resulted in a net loss per share of $0.09, a decrease of $0.28 compared to the net loss per share of $0.37 in the third quarter of fiscal 2004.

Nine months ended March 31, 2005 compared to the nine months ended March 31, 2004

Revenues:

Our revenues totaled approximately $9,330,000 for the first nine months of fiscal 2005, an increase of approximately $3,771,000 or 68% compared to revenues of approximately $5,559,000 for the first nine months of fiscal 2004. Specifically, average selling price increases accounted for $443,000 of the increase, or 12%, while unit volume increases accounted for $2,901,000 million, or 77% of the increase. New products (defined as those introduced in the last twelve months) accounted for sales of $1,796,000, or 19% of sales in the first nine months. New products are defined as unit volume increases in the price and volume disclosures offered herein. We do not foresee any significant change in the dynamics of price and volume from recent experience.

16

Table of Contents

Cost of Sales:

In the first nine months of fiscal 2005, consolidated cost of sales was approximately $7,393,000, or 79% of product sales, versus the comparable period of fiscal 2004 in which we reported cost of sales of approximately $4,443,000, or 80% of product sales. With gross margin rates relatively similar in the two periods hovering around 20%, it was the increase in volume that contributed to the increase in total gross margin. The slight improvement in the gross margin rate, is a result of our continuing efforts to reduce manufacturing costs as a percent of sales through raw material cost reductions and both process and yield improvements. Included in cost of sales in the first nine months of fiscal 2005 was a charge of approximately $265,000 in the Company’s work-in-process inventories to recognize the effect of higher scrap rates in our processes than was embedded in our standard cost. Included in cost of sales for the first nine months of fiscal 2004 was a charge for $69,000 to accrue a liability for an intellectual property license the Company has in order to support a specialty lens product. Subsequently, this lens has been discontinued due to lack of profitability; sales of this lens product were zero in the first nine months of fiscal 2005 and only $199,000 in the first nine months of fiscal 2004.

Selling, General and Administrative:

During the first nine months of fiscal 2005, selling, general and administrative costs (SG&A) of approximately $3,290,000 decreased by approximately $807,000 from the first nine months of fiscal 2004. This decrease is due to reductions in a number of general and administrative expenses during the first nine months of the fiscal year, primarily wages and benefits (approximately $162,000), bonuses and commissions (approximately $51,000), insurance costs (approximately $205,000), in which a significant portion of the reduction was in our D&O insurance renewal, investor relations costs (approximately $126,000), facilities, legal costs and utilities totaling approximately $152,000.

New Product Development:

New product development costs (NPD) increased by approximately $49,000 to approximately $754,000 in the first nine months of fiscal 2005 versus approximately $705,000 in the first nine months of fiscal 2004, due primarily to increases in personnel costs as we added staff to our optical engineering group to better serve our recently higher volumes of business. As we work to achieve profitability at our current level of business, NPD spending will continue to be focused on specific product development work to meet customer design requests that will continue to lead to new and continued sales.

Amortization of Intangibles:

During the first nine months of fiscal 2005, a major component of our identifiable, amortizing intangible assets became fully amortized and, therefore, there was a substantial reduction during the period in amortization of intangibles from the same period in fiscal 2004. Specifically, amortization was $543,000 in the first nine months of 2005 compared to $1,479,000 in the same nine-month period of 2004. The remaining amortization from the acquisitions will be concluded in early fiscal 2006 after which we anticipate amortization expense will be immaterial.

Gain on Sales of Assets:

Gain on sale of assets was approximately $10,000 in the first nine months of fiscal 2005 compared with $115,000 in the same period of fiscal 2004. The assets sold in fiscal 2005 relate to a portion of our lens product line that is suffering from reduced sales; the assets sold in 2004 were a part of our program to dispose of excess equipment from our consolidation of facilities that occurred between December 2002 and June 2003. No significant additional sales or cash proceeds from this excess equipment are expected.

Other Income (Expense):

Due to low balances in our cash equivalents and generally low interest rates available on those balances, our investment income is immaterial in each of the two periods. During the first nine months of fiscal 2005 we did not incur amortization expense related to warrant issuance costs; in the same nine months in fiscal 2004, we recorded amortization of warrant issuance cost of approximately $158,000 for a warrant that was issued in the first quarter of fiscal 2004.

17

Table of Contents

Net Loss:

Net loss was approximately $2,781,000 during the first nine months of fiscal 2005. Included in the net loss were non-cash items of approximately $1.1 million (primarily intangibles amortization and stock based compensation). This compares with the first nine months of fiscal 2004, in which we reported a net loss of approximately $4,429,000, including $1.6 million in similar non-cash charges. The $1.6 million decrease in net loss was due primarily to gross margin improvement of $0.8 million and reduced operating costs of $1.6 million partially offset by a reduction of $0.8 million in other income. The net loss for the first nine months of fiscal 2005 resulted in a net loss per share of $0.84, a decrease of $0.80 compared to the first nine months of fiscal 2004 net loss per share of $1.64.

Critical Accounting Policies and Estimates

The preparation of our Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires us to select appropriate accounting policies, and to make judgments and estimates affecting the application of those accounting policies. In applying the Company’s accounting policies, different business conditions or the use of different assumptions may result in materially different amounts reported in our Consolidated Financial Statements.

In response to the Securities and Exchange Commission’s (SEC) Release No. 33-8040, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, the Company has identified the most critical accounting principles upon which the Company’s financial status depends. The critical principles were determined by considering accounting policies that involve the most complex or subjective decisions or assessments. The most critical accounting principles identified relate to: (i) revenue recognition; (ii) inventory valuation; (iii) long-lived assets; and (iv) intangible assets. These critical accounting policies and the Company’s other significant accounting policies are further disclosed in Note 1 to the Company’s Consolidated Financial Statements.

Revenue recognition. We recognize revenue upon shipment of the product provided that persuasive evidence of a final agreement exists, title has transferred, the selling price is fixed and determinable, and collectibility is reasonably assured.

Inventory valuation. We regularly assess the valuation of inventories and write down those inventories that are obsolete or in excess of forecasted usage to estimated net realizable value. Estimates of realizable value are based upon the Company’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. If market conditions are less favorable than our forecast or actual demand from customers is lower than our estimates, we may be required to record additional inventory write-downs. If demand is higher than expected, we may be able to use or sell inventories that have previously been written down.

Long-Lived Assets. We evaluate the carrying value of long-lived assets, including property and equipment, whenever certain events or changes in circumstances indicate that the carrying amount may not be recoverable. Such events or circumstances include, but are not limited to, a prolonged industry downturn, a significant decline in the Company’s market value, or significant reductions in projected future cash flows. If facts and circumstances warrant such a review, a long-lived asset would be impaired if future undiscounted cash flows, without consideration of interest, are insufficient to recover the carrying amount of the long-lived asset. Once deemed impaired, the long-lived asset is written down to its fair value which could be considerably less than the carrying amount or future undiscounted cash flows. The determination of future cash flows and, if required, fair value of a long-lived asset is, by its nature, a highly subjective judgment. Fair value is generally determined by calculating the discounted future cash flows using a discount rate based upon the Company’s weighted average cost of capital. Significant judgments and assumptions are required in the forecast of future operating results used in the preparation of the estimated future cash flows, including long-term forecasts of the amounts and timing of overall market growth and the Company’s percentage of that market, groupings of assets, discount rate and terminal growth rates. Changes in these estimates could have a material adverse effect on the assessment of property and equipment, thereby requiring us to write down the assets.

Intangible Assets. We have obtained intangible assets in connection with a business unit purchase (for example, in an acquisition). The assignment of value to individual intangible assets generally requires the use of a specialist, such as an appraiser. The assumptions used in the appraisal process are forward-looking, and thus subject to significant judgment. Because individual intangible assets may be: (i) expensed immediately upon acquisition (for example, purchased in-process research and development assets); or (ii) amortized over their estimated useful life (for example, acquired technology), their assigned values could have a material affect on current and future period results of operations. Further, intangible assets are subject to the same judgments when evaluating for impairment as other long-lived assets.

18

Table of Contents

Recent Accounting Pronouncements

On December 16, 2004, the Financial Accounting Standards Board (“FASB”) published Statement of Financial Accounting Standards No. 123 (Revised 2004), Share-Based Payment (“SFAS 123R”). SFAS 123R requires that compensation cost related to share-based payment transactions be recognized in the financial statements. Share-based payment transactions within the scope of SFAS 123R include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans. The Company must comply with the provisions of SFAS 123R when the interim financial statements of the Company for the quarter beginning July 1, 2005 are filed with the Commission. Accordingly, the Company will implement the revised standard in the first quarter of fiscal year 2006, which begins July 1, 2005. Currently, the Company accounts for its share-based payment transactions that are stock options under the provisions of APB 25, which does not necessarily require the recognition of compensation cost in the financial statements. The Company accounts for its share-based payment transactions that are restricted stock agreements or restricted stock units by recognizing compensation expense for the fair value of those instruments under the provisions of SFAS 123. Management is assessing the implications of SFAS 123R, which may materially impact the Company’s results of operations in the first quarter of fiscal year 2006 and thereafter. During the second quarter of fiscal 2005 (three months ended December 31, 2004), the Company’s Compensation Committee considered the matter of the effect of prospective future recognition of compensation expense under SFAS 123R from still outstanding stock options that are significantly “out-of-the money.” The Compensation Committee passed a resolution to accelerate the remaining vesting of such options. These options, totaling 9,900 original shares, held by 18 employees, of which 4,378 shares were accelerated by this resolution, were granted from January 2001 to January 2002 when the Company’s stock price ranged from approximately $93 per share to approximately $27 per share (compared to a trailing 12 month range of $3.25 to $7.52 per share as of January 31, 2005). These options had an original fair value measurement ranging from approximately $67 to $23 per share at the time of the grant and a total remaining prospective recognition of fair value compensation expense of approximately $149,000 at the time of the action by the Compensation Committee. While the Compensation Committee believes that SFAS 123R is a fair resolution to the longstanding issue of equity-based incentive compensation, it does not believe there is true value to the Company by the future recognition of the remaining original fair value expense of options that no longer have any material calculable fair value. Such instruments no longer have any economic value to the employees holding them and no retentive value to the Company with regard to those employees. Once the Company becomes subject to the provisions of SFAS 123R, the Company will recognize expense in accordance with its provisions.

On December 16, 2004, FASB issued Statement of Financial Accounting Standards No. 153, Exchanges of Nonmonetary Assets, an amendment of APB Opinion No. 29, Accounting for Nonmonetary Transactions (“SFAS 153”). This statement amends APB Opinion 29 to eliminate the exception for nonmonetary exchanges of similar productive assets and replaces it with a general exception for exchanges of nonmonetary assets that do not have commercial substance. Under SFAS 153, if a nonmonetary exchange of similar productive assets meets a commercial-substance criterion and fair value is determinable, the transaction must be accounted for at fair value resulting in recognition of any gain or loss. SFAS 153 is effective for nonmonetary transactions in fiscal periods that begin after June 15, 2005. The Company does not anticipate that the implementation of this standard will have a material impact on its financial position, results of operations or cash flows.

Item 3. Quantitative And Qualitative Disclosures About Market Risk

We invest a portion of our cash reserves in a money market fund. The money market fund is not protected under the FDIC; however, the Company has not experienced any losses in these funds. The Company believes that it is not exposed to any significant risk from investing in money market funds.

Item 4. Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management

19

Table of Contents

recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

We carry out a variety of on-going procedures, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, to evaluate the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2005.

PART II

Item 1. Legal Proceedings

In 2000, a group of holders of Class E Common Stock commenced an action in a state court in Texas (the “Texas Action”). Plaintiffs in the Texas Action made various allegations regarding the circumstances surrounding the issuance of the Class E Common Stock and sought damages based upon those allegations. Management believes the allegations underlying the Texas Action are without merit. Since being filed, a Texas court has granted the Company’s motion for Summary Judgment. An appellate court subsequently denied the plaintiff’s motion for reconsideration and the Texas Supreme Court has dismissed a plaintiff’s petition for a review for want of jurisdiction. The plaintiffs subsequently filed another appeal with the 14^th District Court of Appeals in Texas. On November 3, 2004, arguments were heard in that court by a panel of judges. A ruling by the 14^th District Court of Appeals, as to whether to overturn the Summary Judgment and allow a new trial or to affirm that decision, is not expected until mid-year calendar 2005.

The Company licenses certain patents from the University of Florida Research Foundation, Inc. (“UF’). UF notified us that we were in default under the terms of the Amended and Restated License Agreement (“License”) for failure to pay certain royalties. UF claims that we owe $83,000 in unpaid royalties. In April 2004, UF sent its letter of termination of the license. Although we pursued a settlement with UF of its claims for unpaid royalties, such discussions were unsuccessful. We continue to dispute the amount claimed by UF to be owed, although UF has taken no further action in respect of its claims. The termination of the license agreement does not materially adversely affect our business.

During the quarter ended September 30, 2004, the Company settled an employee harassment suit relating to an action filed against the Company’s Geltech subsidiary concerning a pre-acquisition, 1998 incident. The Company has made payments to both the plaintiff and plaintiff’s attorneys totaling $70,000. The action was dismissed upon reaching the settlement.

The Company may also be involved, from time to time, in various claims or actions arising in the normal course of business. After taking into consideration legal counsel’s evaluation of such matters, management is of the opinion that any outcomes will not have a significant effect on the Company’s financial position or results of operations.

Item 6. Exhibits and Reports on Form 8-K

1. The following exhibits are filed herewith as a part of this report.

20

Table of Contents

2. The following reports on Form 8-K were filed under the Securities Exchange Act of 1934 during the quarter ended March 31, 2005:

21

Table of Contents

1. SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

22